Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography, Circulation, vol.83, issue.3, pp.875-885, 1991. ,
DOI : 10.1161/01.CIR.83.3.875
Efficacy of a ??-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration, Cardiovascular Research, vol.37, issue.3, pp.646-655, 1998. ,
DOI : 10.1016/S0008-6363(97)00304-0
Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: Possible aggravation by myocardial ischemia?Study in the porcine in situ heart, Cardiovascular Drugs and Therapy, vol.49, issue.2, pp.217-223, 1993. ,
DOI : 10.1007/BF00878511
Profibrillatory Effects of Lidocaine in the Acutely Ischemic Porcine Heart, Journal of Cardiovascular Pharmacology, vol.25, issue.5, pp.810-816, 1995. ,
DOI : 10.1097/00005344-199505000-00018
Basic Biology and Pharmacology of the Cardiac Sarcolemmal Sodium/Hydrogen Exchanger, Journal of Cardiac Surgery, vol.102, issue.s1, pp.3-12, 2003. ,
DOI : 10.1046/j.1540-8191.18.s1.2.x
Universal biological scaling and mortality., Proceedings of the National Academy of Sciences, vol.91, issue.26, pp.12453-12457, 1994. ,
DOI : 10.1073/pnas.91.26.12453
A Meta-Analysis of 94,492 Patients With Hypertension Treated With Beta Blockers to Determine the Risk of New-Onset Diabetes Mellitus, The American Journal of Cardiology, vol.100, issue.8, pp.1254-1262, 2007. ,
DOI : 10.1016/j.amjcard.2007.05.057
Physiology and pharmacology of the cardiac pacemaker (???funny???) current, Pharmacology & Therapeutics, vol.107, issue.1, pp.59-79, 2005. ,
DOI : 10.1016/j.pharmthera.2005.01.005
Hemodynamic stress and experimental aortoiliac atherosclerosis, Journal of Vascular Surgery, vol.19, issue.3, pp.426-434, 1994. ,
DOI : 10.1016/S0741-5214(94)70069-9
Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion, American Journal of Physiology - Heart and Circulatory Physiology, vol.285, issue.3, pp.1064-1071, 2003. ,
DOI : 10.1152/ajpheart.00124.2003
Microvascular Oxygenation and Oxidative Stress During Postischemic Reperfusion, Adv Exp Med Biol, vol.566, pp.23-29, 2005. ,
DOI : 10.1007/0-387-26206-7_4
Cardiac HCN Channels Structure, Function, and Modulation, Trends in Cardiovascular Medicine, vol.12, issue.5, pp.206-212, 2002. ,
DOI : 10.1016/S1050-1738(02)00162-7
Loss of cardioprotection with ageing, Cardiovascular Research, vol.83, issue.2, pp.247-261, 2009. ,
DOI : 10.1093/cvr/cvp033
Isolated cells of the frog sinus venosus: properties of the inward current activated during hyperpolarization, Pfl???gers Archiv European Journal of Physiology, vol.385, issue.3, pp.339-346, 1990. ,
DOI : 10.1007/BF00392071
Antianginal and Antiischemic Effects of Ivabradine, an If Inhibitor, in Stable Angina: A Randomized, Double-Blind, Multicentered, Placebo-Controlled Trial, Circulation, vol.107, issue.6, pp.817-823, 2003. ,
DOI : 10.1161/01.CIR.0000048143.25023.87
Reduced Myocardial Creatine Kinase Flux in Human Myocardial Infarction: An In Vivo Phosphorus Magnetic Resonance Spectroscopy Study, Circulation, vol.119, issue.14, pp.1918-1924, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.823187
Cardiac pacemaker oscillation and its modulation by autonomic transmitters, J Exp Biol, vol.81, pp.175-204, 1979. ,
Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ, Pharmacotherapy, vol.17, issue.4, pp.737-745, 1997. ,
Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology, Drugs in R & D, vol.15, issue.2, pp.83-89, 2003. ,
DOI : 10.2165/00126839-200304020-00001
Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era, American Heart Journal, vol.158, issue.3, pp.467-472, 2009. ,
DOI : 10.1016/j.ahj.2009.06.028
Protons in ischemia: Where do they come from; Where do they go to?, Journal of Molecular and Cellular Cardiology, vol.23, issue.9, pp.1077-1086, 1991. ,
DOI : 10.1016/0022-2828(91)91642-5
Interference of 3-hydroxyisobutyrate with measurements of ketone body concentration and isotopic enrichment by gas chromatography-mass spectrometry, Analytical Biochemistry, vol.173, issue.1, pp.96-105, 1988. ,
DOI : 10.1016/0003-2697(88)90165-0
CHANGES IN THE IN VITRO PHARMACODYNAMIC PROPERTIES OF METOPROLOL IN ATRIA ISOLATED FROM SPONTANEOUSLY HYPERTENSIVE RATS, Clinical and Experimental Pharmacology and Physiology, vol.268, issue.3, pp.161-165, 2007. ,
DOI : 10.1126/science.8160017
In Vitro and In Vivo Pharmacodynamic Properties of Metoprolol in Fructose-fed Hypertensive Rats, Journal of Cardiovascular Pharmacology, vol.51, issue.6, pp.532-541, 2008. ,
DOI : 10.1097/FJC.0b013e3181730306
Heart Rate Slowing versus Other Pharmacological Antianginal Strategies, Adv Cardiol, vol.43, pp.65-78, 2006. ,
DOI : 10.1159/000095429
current and its inhibition by heart rate-reducing agents, Current Medical Research and Opinion, vol.21, issue.7, pp.1115-1122, 2005. ,
DOI : 10.1185/030079905X50543
Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine, Drugs, vol.109, issue.16, pp.1757-1765, 2004. ,
DOI : 10.2165/00003495-200464160-00003
Muscarinic modulation of cardiac rate at low acetylcholine concentrations, Science, vol.243, issue.4891, pp.669-671, 1989. ,
DOI : 10.1126/science.2916119
Inhibition of the hyperpolarization-activated current (if) induced by acetylcholine in rabbit sino-atrial node myocytes., The Journal of Physiology, vol.405, issue.1, pp.477-491, 1988. ,
DOI : 10.1113/jphysiol.1988.sp017343
Myocardial oxygen requirements during experimental cardiopulmonary resuscitation, Cardiovascular Research, vol.26, issue.8, pp.791-797, 1992. ,
DOI : 10.1093/cvr/26.8.791
CALCIUM IN CELL INJURY AND DEATH, Annual Review of Pathology: Mechanisms of Disease, vol.1, issue.1, pp.405-434, 2006. ,
DOI : 10.1146/annurev.pathol.1.110304.100218
HEART RATE AS A PROGNOSTIC FACTOR FOR CORONARY HEART DISEASE AND MORTALITY: FINDINGS IN THREE CHICAGO EPIDEMIOLOGIC STUDIES, American Journal of Epidemiology, vol.112, issue.6, pp.736-749, 1980. ,
DOI : 10.1093/oxfordjournals.aje.a113046
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo, New England Journal of Medicine, vol.324, issue.12, pp.781-788, 1991. ,
DOI : 10.1056/NEJM199103213241201
[Arrhythmogenic risk of antiarrhythmic drugs: study with class Ic drugs during myocardial ischemia], Bull Acad Natl Med, vol.175, issue.2, pp.217-224, 1991. ,
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning, Pharmacological Reviews, vol.59, issue.4, pp.418-458, 2007. ,
DOI : 10.1124/pr.107.06002
Correction of13C Mass Isotopomer Distributions for Natural Stable Isotope Abundance, Journal of Mass Spectrometry, vol.31, issue.3, pp.255-262, 1996. ,
DOI : 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3
Ischaemic heart disease: clinical improvement with metabolic approach, Rev Port Cardiol, vol.19, issue.5, pp.7-20, 2000. ,
Anti-ischaemic effect of ivabradine, Pharmacological Research, vol.53, issue.5, pp.435-439, 2006. ,
DOI : 10.1016/j.phrs.2006.03.018
On the Innervation of the Heart, with especial reference to the Heart of the Tortoise, The Journal of Physiology, vol.4, issue.2-3, pp.43-230, 1883. ,
DOI : 10.1113/jphysiol.1883.sp000121
Myocardial protection during ventricular fibrillation by inhibition of the sodium-hydrogen exchanger isoform-1, Critical Care Medicine, vol.30, issue.Supplement, pp.166-171, 2002. ,
DOI : 10.1097/00003246-200204001-00010
Myocardial effects of ventricular fibrillation in the isolated rat heart, Critical Care Medicine, vol.27, issue.8, pp.1542-1550, 1999. ,
DOI : 10.1097/00003246-199908000-00023
Elevated heart rate and atherosclerosis: An overview of the pathogenetic mechanisms, International Journal of Cardiology, vol.126, issue.3, pp.302-312, 2008. ,
DOI : 10.1016/j.ijcard.2007.08.077
Increased Exchange Current but Normal Ca2+ Transport via Na+-Ca2+ Exchange During Cardiac Hypertrophy After Myocardial Infarction, Circulation Research, vol.91, issue.4, pp.323-330, 2002. ,
DOI : 10.1161/01.RES.0000031384.55006.DB
Pharmacodynamics of Carvedilol in Conscious, Healthy Dogs, Journal of Veterinary Internal Medicine, vol.85, issue.9A, pp.297-304, 2006. ,
DOI : 10.1111/j.1939-1676.2006.tb02860.x
Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance, AJP: Heart and Circulatory Physiology, vol.297, issue.1, pp.59-64, 2009. ,
DOI : 10.1152/ajpheart.00178.2009
Mechanism of beneficial effect of beta-adrenergic blockade on exercise- induced myocardial ischemia in conscious dogs, Circulation Research, vol.60, issue.5, pp.738-746, 1987. ,
DOI : 10.1161/01.RES.60.5.738
Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells., The Journal of Physiology, vol.395, issue.1, pp.233-253, 1988. ,
DOI : 10.1113/jphysiol.1988.sp016916
The heart rate hypothesis: ready to be tested, Heart, vol.94, issue.5, pp.561-565, 2008. ,
DOI : 10.1136/hrt.2007.118760
Comparison of Ion-Channel Subunit Expression in Canine Cardiac Purkinje Fibers and Ventricular Muscle, Circulation Research, vol.91, issue.9, pp.790-797, 2002. ,
DOI : 10.1161/01.RES.0000039534.18114.D9
Tracing Gluconeogenesis with Deuterated Water: Measurement of Low Deuterium Enrichments on Carbons 6 and 2 of Glucose, Analytical Biochemistry, vol.248, issue.1, pp.158-167, 1997. ,
DOI : 10.1006/abio.1997.2068
Left Ventricular Muscle Mass and Elevated Heart Rate Are Associated With Coronary Plaque Disruption, Circulation, vol.104, issue.13, pp.1477-1482, 2001. ,
DOI : 10.1161/hc3801.096325
Vasoactive intestinal peptide: cardiovascular effects, Cardiovascular Research, vol.49, issue.1, pp.27-37, 2001. ,
DOI : 10.1016/S0008-6363(00)00229-7
Evaluation of myocardial metabolism, with N-13-and C-11-labeled amino acids and positron computed tomography, J Nucl Med, vol.23, issue.8, pp.671-681, 1982. ,
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents, British Journal of Pharmacology, vol.425, issue.Suppl L, pp.1589-1601, 2008. ,
DOI : 10.1038/sj.bjp.0707673
??-Adrenergic Coronary Vasoconstriction and Myocardial Ischemia in Humans, Circulation, vol.101, issue.6, pp.689-694, 2000. ,
DOI : 10.1161/01.CIR.101.6.689
Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction, European Heart Journal, vol.29, issue.18, pp.2265-2275, 2008. ,
DOI : 10.1093/eurheartj/ehn337
Meta-analytic Evidence Against Prophylactic Use of Lidocaine in Acute Myocardial Infarction, Archives of Internal Medicine, vol.149, issue.12, pp.2694-2698, 1989. ,
DOI : 10.1001/archinte.1989.00390120056011
Rapid measurement of cerebral blood flow with positron emission tomography, Ciba Found Symp, vol.163, pp.23-37, 1991. ,
Heart rate reduction improves myocardial ischemia in swine: role of interventricular blood flow redistribution, Am J Physiol, vol.261, pp.910-917, 1991. ,
The role of heart rate in myocardial ischemia and infarction: Implications of myocardial perfusion-contraction matching, Progress in Cardiovascular Diseases, vol.36, issue.1, pp.61-74, 1993. ,
DOI : 10.1016/0033-0620(93)90022-6
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators, N Engl J Med, vol.321, issue.6, pp.406-412, 1989. ,
Molecular Characterization of the Hyperpolarization-activated Cation Channel in Rabbit Heart Sinoatrial Node, Journal of Biological Chemistry, vol.274, issue.18, pp.12835-12839, 1999. ,
DOI : 10.1074/jbc.274.18.12835
Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction, Physiol Rev, vol.69, issue.4, pp.1049-1169, 1989. ,
High Energy Phosphates, Anaerobic Glycolysis and Irreversibility in Ischemia, Adv Exp Med Biol, vol.161, pp.403-419, 1983. ,
DOI : 10.1007/978-1-4684-4472-8_23
Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise, British Journal of Clinical Pharmacology, vol.1, issue.2, pp.127-137, 2006. ,
DOI : 10.1161/01.CIR.0000118464.48959.1C
Heart-Rate Profile during Exercise as a Predictor of Sudden Death, New England Journal of Medicine, vol.352, issue.19, pp.1951-1958, 2005. ,
DOI : 10.1056/NEJMoa043012
Metoprolol Prevents Ischemia-Reperfusion Injury by Reducing Lipid Peroxidation, Japanese Circulation Journal, vol.63, issue.9, pp.718-721, 1999. ,
DOI : 10.1253/jcj.63.718
The influence of heart rate on coronary artery atherosclerosis, J Cardiovasc Pharmacol, vol.10, issue.103, pp.100-102, 1987. ,
Molecular Diversity of Pacemaker Ion Channels, Annual Review of Physiology, vol.63, issue.1, pp.235-257, 2001. ,
DOI : 10.1146/annurev.physiol.63.1.235
The Form and Nature of the Muscular Connections between the Primary Divisions of the Vertebrate Heart, J Anat Physiol, vol.41, pp.172-189, 1907. ,
Intramyocardial hypercarbic acidosis during cardiac arrest and resuscitation, Critical Care Medicine, vol.21, issue.6, pp.901-906, 1993. ,
DOI : 10.1097/00003246-199306000-00020
Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons, AJP: Heart and Circulatory Physiology, vol.286, issue.4, pp.1461-1470, 2004. ,
DOI : 10.1152/ajpheart.00942.2003
Re-examining the efficacy of ??-blockers for the treatment of hypertension: a meta-analysis, Canadian Medical Association Journal, vol.174, issue.12, pp.1737-1742, 2006. ,
DOI : 10.1503/cmaj.060110
Stable isotope model for assessing production of short chain fatty acids from colonderived sugar: application in pigs, J Nutr, vol.126, issue.12, pp.3069-3076, 1996. ,
Glucose and glycogen utilisation in myocardial ischemia ??? Changes in metabolism and consequences for the myocyte, Mol Cell Biochem, vol.180, issue.12, pp.3-26, 1998. ,
DOI : 10.1007/978-1-4615-5687-9_1
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1, Circulation, vol.104, issue.24, pp.2981-2989, 2001. ,
DOI : 10.1161/hc4801.100038
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 2, Circulation, vol.104, issue.25, pp.3158-3167, 2001. ,
DOI : 10.1161/hc5001.100039
Effect of Ischemic Preconditioning on Mitochondrial Oxidative Phosphorylation and High Energy Phosphates in Rat Hearts, Journal of Molecular and Cellular Cardiology, vol.28, issue.2, pp.417-428, 1996. ,
DOI : 10.1006/jmcc.1996.0038
Pharmacological therapy in coronary heart disease: Prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death, European Heart Journal, vol.14, issue.suppl E, pp.107-119, 1993. ,
DOI : 10.1093/eurheartj/14.suppl_E.107
Ventricular Tachycardia and Sudden Cardiac Death, Mayo Clinic Proceedings, vol.84, issue.3, pp.289-297, 2009. ,
DOI : 10.4065/84.3.289
Vasopressin during cardiopulmonary resuscitation: A progress report, Critical Care Medicine, vol.32, issue.Supplement, pp.432-435, 2004. ,
DOI : 10.1097/01.CCM.0000134267.91520.C0
Medium-chain Fatty Acids as Metabolic Therapy in Cardiac Disease, Cardiovascular Drugs and Therapy, vol.83, issue.2, pp.97-106, 2008. ,
DOI : 10.1007/s10557-008-6084-0
Fatty acid oxidation and its impact on response of spontaneously hypertensive rat hearts to an adrenergic stress: benefits of a medium-chain fatty acid, AJP: Heart and Circulatory Physiology, vol.288, issue.3, pp.1425-1436, 2005. ,
DOI : 10.1152/ajpheart.00722.2004
Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment, American Journal of Ophthalmology, vol.134, issue.5, pp.749-760, 2002. ,
DOI : 10.1016/S0002-9394(02)01699-9
Use of labeling pattern of liver glutamate to calculate rates of citric acid cycle and gluconeogenesis, Am J Physiol, vol.2721, issue.1 ,
N??ud sinusal et canaux ioniques : physiologie et r??gulation, Th??rapie, vol.59, issue.5, pp.491-494, 2004. ,
DOI : 10.2515/therapie:2004085
Mitochondrial Dysfunction in Cardiac Disease: Ischemia???Reperfusion, Aging, and Heart Failure, Journal of Molecular and Cellular Cardiology, vol.33, issue.6, pp.1065-1089, 2001. ,
DOI : 10.1006/jmcc.2001.1378
Rest heart rate and life expectancy, J Am Coll Cardiol, vol.30, issue.4, pp.1104-1106, 1997. ,
Antiapoptosis and Mitochondrial Effect of Pioglitazone Preconditioning in the Ischemic/reperfused Heart of Rat, Cardiovascular Drugs and Therapy, vol.401, issue.4, pp.283-291, 2008. ,
DOI : 10.1007/s10557-008-6115-x
Past and present course of cardioprotection against ischemia- reperfusion injury, Journal of Applied Physiology, vol.103, issue.6, pp.2129-2136, 2007. ,
DOI : 10.1152/japplphysiol.00383.2007
In Vivo Effects of Myocardial Creatine Depletion on Left Ventricular Function Morphology and Lipid Metabolism: Study in a Mouse Model, Journal of Cardiac Failure, vol.14, issue.2, pp.161-166, 2008. ,
DOI : 10.1016/j.cardfail.2007.10.020
Low succinate dehydrogenase (SDH) activity in a patient with a hereditary myopathy with paroxysmal myoglobinuria, Journal of Internal Medicine, vol.38, issue.Suppl. 358, pp.43-52, 1990. ,
DOI : 10.1111/j.1365-2796.1990.tb00191.x
Should ?? blockers remain first choice in the treatment of primary hypertension? A meta-analysis, The Lancet, vol.366, issue.9496, pp.1545-1553, 2005. ,
DOI : 10.1016/S0140-6736(05)67573-3
Epinephrine and Norepinephrine in Cardiopulmonary Resuscitation, Chest, vol.97, issue.6, pp.1458-1462, 1990. ,
DOI : 10.1378/chest.97.6.1458
Exercise and the Coronary Circulation???Alterations and Adaptations in Coronary Artery Disease, Progress in Cardiovascular Diseases, vol.48, issue.4, pp.270-284, 2006. ,
DOI : 10.1016/j.pcad.2005.10.001
Mitochondrial ATPase and high-energy phosphates in failing hearts ,
Long-Term Safety and Efficacy of Ivabradine in Patients with Chronic Stable Angina, Cardiology, vol.108, issue.4, pp.387-396, 2007. ,
DOI : 10.1159/000108387
Structure and Function of Cardiac Pacemaker Channels, Cellular Physiology and Biochemistry, vol.9, issue.4-5, pp.179-186, 1999. ,
DOI : 10.1159/000016315
Maximum oxidative phosphorylation capacity of the mammalian heart, Am J Physiol, vol.272, issue.2 2, pp.769-775, 1997. ,
Mitochondrial MMP Activation, Dysfunction and Arrhythmogenesis in Hyperhomocysteinemia, Current Vascular Pharmacology, vol.6, issue.2, pp.84-92, 2008. ,
DOI : 10.2174/157016108783955301
Heart Rate Slowing for Myocardial Dysfunction/Heart Failure, Adv Cardiol, vol.43, pp.97-105, 2006. ,
DOI : 10.1159/000095431
Colorimetric method for the measurement of isocitric dehydrogenase activity, J Lab Clin Med, vol.62, pp.148-158, 1963. ,
Relationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle, Annual Review of Physiology, vol.36, issue.1, pp.413-459, 1974. ,
DOI : 10.1146/annurev.ph.36.030174.002213
Influence of left ventricular pressures and heart rate on myocardial high-energy phosphate metabolism, Basic Research in Cardiology, vol.93, issue.0, pp.102-107, 1998. ,
DOI : 10.1007/s003950050231
The Failing Heart ??? An Engine Out of Fuel, New England Journal of Medicine, vol.356, issue.11, pp.1140-1151, 2007. ,
DOI : 10.1056/NEJMra063052
Estimation of myocardial ischemic injury during ventricular fibrillation with total circulatory arrest using high-energy phosphates and lactate as metabolic markers, Annals of Emergency Medicine, vol.20, issue.3, pp.222-229, 1991. ,
DOI : 10.1016/S0196-0644(05)80927-8
Treatment of prolonged ventricular fibrillation. Immediate countershock versus high-dose epinephrine and CPR preceding countershock, Circulation, vol.85, issue.1, pp.281-287, 1992. ,
DOI : 10.1161/01.CIR.85.1.281
Mammalian xanthine oxidoreductase - mechanism of transition from xanthine dehydrogenase to xanthine oxidase, FEBS Journal, vol.281, issue.13, pp.3278-3289, 2008. ,
DOI : 10.1111/j.1742-4658.2008.06489.x
Heart Rate Is a Marker of Amiodarone Mortality Reduction in Severe Heart Failure, The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia ,
DOI : 10.1016/S0735-1097(97)00066-1
Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity, Journal of Hypertension, vol.24, issue.7, pp.1375-1381, 2006. ,
DOI : 10.1097/01.hjh.0000234118.25401.1c
Mechanisms of the defect in cardiac myofibrillar function during diabetes, Am J Physiol, vol.2482, issue.1, pp.170-175, 1985. ,
Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell, Cardiovascular Research, vol.28, issue.1, pp.1-15, 1994. ,
DOI : 10.1093/cvr/28.1.1
Exchanger in the Rabbit, The Journal of Physiology, vol.273, issue.1, pp.229-242, 2003. ,
DOI : 10.1113/jphysiol.2003.050716
Between nitros(yl)ation and nitration: Regulation of thioredoxin-1 in myocardial ischemia/reperfusion injury, Journal of Molecular and Cellular Cardiology, vol.49, issue.3, 2010. ,
DOI : 10.1016/j.yjmcc.2010.06.001
The role of heart rate in the development of cardiovascular disease, Clinical Research in Cardiology, vol.91, issue.9, pp.585-592, 2007. ,
DOI : 10.1007/s00392-007-0537-5
Heart Rate Reduction by If-Channel Inhibition and its Potential Role in Heart Failure with Reduced and Preserved Ejection Fraction, Trends in Cardiovascular Medicine, vol.19, issue.5, pp.152-157, 2009. ,
DOI : 10.1016/j.tcm.2009.09.002
Time to give the first medication during resuscitation in out-of-hospital cardiac arrest, Resuscitation, vol.70, issue.2, pp.201-206, 2006. ,
DOI : 10.1016/j.resuscitation.2005.12.006
Capillary gas-liquid chromatographic/mass spectrometric measurement of plasma acetate content and (2-13C) acetate enrichment, Biological Mass Spectrometry, vol.248, issue.9, pp.816-819, 1989. ,
DOI : 10.1002/bms.1200180927
Sudden death during longterm ambulatory monitoring, European Heart Journal, vol.5, issue.1, pp.7-20, 1984. ,
DOI : 10.1093/oxfordjournals.eurheartj.a061555
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects., Proceedings of the National Academy of Sciences, vol.93, issue.14, pp.7375-7380, 1996. ,
DOI : 10.1073/pnas.93.14.7375
Heart rate in ischemic heart disease. The innovation of ivabradine: More than pure heart rate reduction, Advances in Therapy, vol.30, issue.4, pp.202-210, 2010. ,
DOI : 10.1007/s12325-010-0030-9
Quickening the Pace, Neuron, vol.42, issue.2, pp.193-196, 2004. ,
DOI : 10.1016/S0896-6273(04)00199-0
Mechanisms of sudden cardiac death, Journal of Clinical Investigation, vol.115, issue.9, pp.2305-2315, 2005. ,
DOI : 10.1172/JCI26381
Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris, Drugs, vol.152, issue.23, pp.393-405, 2007. ,
DOI : 10.2165/00003495-200767030-00005
If at first you don't succeed try ... a new target in the treatment of angina, European Heart Journal, vol.26, issue.23, pp.2482-2483, 2005. ,
DOI : 10.1093/eurheartj/ehi575
Computational studies of the effects of myocardial blood flow reductions on cardiac metabolism, BioMedical Engineering OnLine, vol.3, issue.1, p.15, 2004. ,
DOI : 10.1186/1475-925X-3-15
Identification of a Gene Encoding a Hyperpolarization-Activated Pacemaker Channel of Brain, Cell, vol.93, issue.5, pp.717-729, 1998. ,
DOI : 10.1016/S0092-8674(00)81434-8
Sudden cardiac death: epidemiology and temporal trends, Rev Cardiovasc Med, vol.6, issue.2, pp.12-20, 2005. ,
Relationship between myocardial metabolites and contractile abnormalities during graded regional ischemia. Phosphorus-31 nuclear magnetic resonance studies of porcine myocardium in vivo., Journal of Clinical Investigation, vol.85, issue.3, pp.706-713, 1990. ,
DOI : 10.1172/JCI114495
electrocardiogram of me month: Ventricular Aneurysm: The Effect of a Complicating Left Anterior Hemiblock, Chest, vol.85, issue.2, pp.276-277, 1984. ,
DOI : 10.1378/chest.85.2.276
Inorganic phosphate inhibits contractility and ATPase activity in skinned fibers from human myocardium, Basic Research in Cardiology, vol.27, issue.3, pp.358-366, 1990. ,
DOI : 10.1007/BF01907128
Pharmacological preconditioning with diazoxide slows energy metabolism during sustained ischemia, Exp Clin Cardiol, vol.12, issue.3, pp.139-147, 2007. ,
Energetic myocardial metabolism and oxidative stress: Let's make them our friends in the fight against heart failure, Biomedicine & Pharmacotherapy, vol.64, issue.3, pp.203-207, 2010. ,
DOI : 10.1016/j.biopha.2009.10.002
Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat, AJP: Heart and Circulatory Physiology, vol.294, issue.4, pp.1609-1620, 2008. ,
DOI : 10.1152/ajpheart.00949.2007
Electrophysiologic Effects of Acute Myocardial Ischemia: A Mechanistic Investigation of Action Potential Conduction and Conduction Failure, Circulation Research, vol.80, issue.1, pp.124-138, 1997. ,
DOI : 10.1161/01.RES.80.1.124
Distribution and Prevalence of Hyperpolarization-Activated Cation Channel (HCN) mRNA Expression in Cardiac Tissues, Circulation Research, vol.85, issue.1, pp.1-6, 1999. ,
DOI : 10.1161/01.RES.85.1.e1
Why Does the Heart Beat?: The Discovery of the Electrical System of the Heart, Circulation, vol.113, issue.23, pp.2775-2781, 2006. ,
DOI : 10.1161/CIRCULATIONAHA.106.616771
Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs, J Pharmacol Exp Ther, vol.275, issue.2, pp.659-666, 1995. ,
??-Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Compounds: An Overview, Journal of Cardiovascular Pharmacology and Therapeutics, vol.10, issue.4 suppl, pp.3-14, 2005. ,
DOI : 10.1177/10742484050100i402
The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia???reperfusion injury?????????, European Journal of Cardio-Thoracic Surgery, vol.33, issue.5, pp.906-913, 2008. ,
DOI : 10.1016/j.ejcts.2008.01.047
Myocardial Substrate Metabolism in the Normal and Failing Heart, Physiological Reviews, vol.85, issue.3, pp.1093-1129, 2005. ,
DOI : 10.1152/physrev.00006.2004
Advanced Cardiac Life Support in Out-of-Hospital Cardiac Arrest, New England Journal of Medicine, vol.351, issue.7, pp.647-656, 2004. ,
DOI : 10.1056/NEJMoa040325
Spatial heterogeneity of myocardial perfusion predicts local potassium channel expression and action potential duration, Cardiovascular Research, vol.77, issue.3, pp.489-496, 2008. ,
DOI : 10.1093/cvr/cvm060
Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group, Circulation, vol.82, issue.6, pp.1962-1972, 1990. ,
DOI : 10.1161/01.CIR.82.6.1962
Ivabradine - the first selective sinus node If channel inhibitor in the treatment of stable angina, International Journal of Clinical Practice, vol.4, issue.Suppl. 1, pp.222-228, 2006. ,
DOI : 10.1111/j.1742-1241.2006.00817.x
Clinical Results of If Current Inhibition by Ivabradine, Drugs, vol.27, issue.4, pp.35-41, 2007. ,
DOI : 10.2165/00003495-200767002-00005
Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina, European Heart Journal, vol.26, issue.23, pp.2529-2536, 2005. ,
DOI : 10.1093/eurheartj/ehi586
Das Reizleitungssystem Des Säugetierherzens [The Conduction System of the Mammalian Heart], 1906. ,
Differential Expression of Ion Channel Transcripts in Atrial Muscle and Sinoatrial Node in Rabbit, Circulation Research, vol.99, issue.12, pp.1384-1393, 2006. ,
DOI : 10.1161/01.RES.0000251717.98379.69
Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49, British Journal of Pharmacology, vol.8, issue.Suppl. L, pp.37-42, 1994. ,
DOI : 10.1111/j.1476-5381.1994.tb13025.x
Impact of Sleep on Arrhythmogenesis, Circulation: Arrhythmia and Electrophysiology, vol.2, issue.4, pp.450-459, 2009. ,
DOI : 10.1161/CIRCEP.109.867028
T-Wave Alternans as a Therapeutic Marker for Antiarrhythmic Agents, Journal of Cardiovascular Pharmacology, vol.55, issue.6, pp.544-554, 2010. ,
DOI : 10.1097/FJC.0b013e3181d6b781
Heart rate, autonomic markers, and cardiac mortality, Heart Rhythm, vol.6, issue.11, pp.68-75, 2009. ,
DOI : 10.1016/j.hrthm.2009.07.017
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2776094
: Une nouvelle approche th??rapeutique des cardiopathies isch??miques, m??decine/sciences, vol.22, issue.1, pp.87-94, 2006. ,
DOI : 10.1051/medsci/200622187
URL : http://www.erudit.org/revue/ms/2006/v22/n1/012240ar.pdf
Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs, Journal of Cardiovascular Pharmacology, vol.42, issue.5, pp.688-696, 2003. ,
DOI : 10.1097/00005344-200311000-00016
Phénotypage métabolique du coeur sain et malade basé sur l'analyse d'isotopomères de masse marqués au carbone 13: implications du citrate ,
Metabolic phenotyping of the diseased rat heart using 13C-substrates and ex vivo perfusion in the working mode, Mol Cell Biochem, vol.242, issue.12, pp.89-99, 2003. ,
DOI : 10.1007/978-1-4757-4712-6_12
Myocardial energy metabolism in ischemic preconditioning and cardioplegia: A metabolic control analysis, Molecular and Cellular Biochemistry, vol.198, issue.1-2, pp.223-232, 2005. ,
DOI : 10.1007/s11010-005-7576-x
Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1690, issue.2, pp.177-184, 2004. ,
DOI : 10.1016/j.bbadis.2004.06.004
Modification of Myosin Gene Expression by Imidapril in Failing Heart due to Myocardial Infarction, Journal of Molecular and Cellular Cardiology, vol.34, issue.7, pp.847-857, 2002. ,
DOI : 10.1006/jmcc.2002.2023
Sodium???Hydrogen Exchange Inhibition and ??-Blockade Additively Decrease Infarct Size, The Annals of Thoracic Surgery, vol.83, issue.3, pp.1121-1127, 2007. ,
DOI : 10.1016/j.athoracsur.2006.10.039
Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury, Journal of Applied Physiology, vol.103, issue.1, pp.55-65, 2007. ,
DOI : 10.1152/japplphysiol.01167.2006
Regional Myocardial Metabolism of High-Energy Phosphates during Isometric Exercise in Patients with Coronary Artery Disease, New England Journal of Medicine, vol.323, issue.23, pp.1593-1600, 1990. ,
DOI : 10.1056/NEJM199012063232304
Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts, The Journal of Physiology, vol.94, issue.17, pp.4193-4208, 2008. ,
DOI : 10.1113/jphysiol.2008.154732
Structural basis for modulation and agonist specificity of HCN pacemaker channels, Nature, vol.425, issue.6954, pp.200-205, 2003. ,
DOI : 10.1038/nature01922
Altered Proteome Biology of Cardiac Mitochondria Under Stress Conditions, Journal of Proteome Research, vol.7, issue.6, pp.2204-2214, 2008. ,
DOI : 10.1021/pr070371f
Myocardial apoptosis and ischemic preconditioning, Cardiovascular Research, vol.55, issue.3, pp.438-455, 2002. ,
DOI : 10.1016/S0008-6363(02)00442-X
Bradycardia-Induced Coronary Angiogenesis Is Dependent on Vascular Endothelial Growth Factor, Circulation Research, vol.85, issue.2, pp.192-198, 1999. ,
DOI : 10.1161/01.RES.85.2.192
Sudden death during longterm ambulatory monitoring, European Heart Journal, vol.5, issue.1, pp.7-20, 1984. ,
DOI : 10.1093/oxfordjournals.eurheartj.a061555
Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction, Physiol Rev, vol.69, pp.1049-1169, 1989. ,
Class Ic antiarrhythmic drugs and myocardial ischaemia: study in the pig heart in situ, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.343, issue.6, pp.645-651, 1991. ,
DOI : 10.1007/BF00184297
Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: Possible aggravation by myocardial ischemia?Study in the porcine in situ heart, Cardiovascular Drugs and Therapy, vol.49, issue.2, pp.217-223, 1993. ,
DOI : 10.1007/BF00878511
Profibrillatory Effects of Lidocaine in the Acutely Ischemic Porcine Heart, Journal of Cardiovascular Pharmacology, vol.25, issue.5, pp.810-816, 1995. ,
DOI : 10.1097/00005344-199505000-00018
Cardiac ??-adrenoceptor activation and ventricular fibrillation under normal and ischaemic conditions, Cardiovascular Research, vol.32, issue.6, pp.1056-1063, 1996. ,
DOI : 10.1016/S0008-6363(96)00156-3
Efficacy of a ??-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fibrillation: dependence on heart rate and ischaemia duration, Cardiovascular Research, vol.37, issue.3, pp.646-655, 1998. ,
DOI : 10.1016/S0008-6363(97)00304-0
Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine, Drugs, vol.109, issue.16, pp.1757-1765, 2004. ,
DOI : 10.2165/00003495-200464160-00003
Differential effects of heart rate reduction and beta-blockade on left ventricular relaxation during exercise ,
Long-Term Heart Rate Reduction Induced by the Selective If Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in Congestive Heart Failure, Circulation, vol.109, issue.13, pp.1674-1679, 2004. ,
DOI : 10.1161/01.CIR.0000118464.48959.1C
Coronary and hemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs, J Pharmacol Exp Ther, vol.275, pp.659-666, 1995. ,
Anti-Ischemic Effects of Ivabradine, a Selective Heart Rate-Reducing Agent, in Exercise-Induced Myocardial Ischemia in Pigs, Journal of Cardiovascular Pharmacology, vol.42, issue.5, pp.688-696, 2003. ,
DOI : 10.1097/00005344-200311000-00016
Contributions of heart rate and contractility to myocardial oxygen balance during exercise, American Journal of Physiology - Heart and Circulatory Physiology, vol.284, issue.2, pp.676-682, 2003. ,
DOI : 10.1152/ajpheart.00564.2002
Effects of heart rate reduction with ivabradine on exercise-induced myocardial ischemia and stunning ,
Heart rate reduction during exercise-induced myocardial ischaemia and stunning, European Heart Journal, vol.25, issue.7, pp.579-586, 2004. ,
DOI : 10.1016/j.ehj.2003.10.010
Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257, European Journal of Pharmacology, vol.339, issue.1, pp.43-51, 1997. ,
DOI : 10.1016/S0014-2999(97)01364-2
Quantitative morphometry of myocardial necrosis Anatomical and enzymatic correlates, clinical index for estimating the amount of necrosed tissue, Arch Mal Coeur Vaiss, vol.74, pp.641-648, 1981. ,
Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization, Canadian Journal of Physiology and Pharmacology, vol.78, issue.3, pp.208-216, 2000. ,
DOI : 10.1139/y99-129
Trimetazidine Protective Effect Against Ischemia-Induced Susceptibility to Ventricular Fibrillation in Pigs, Cardiovascular Drugs and Therapy, vol.79, issue.1, pp.29-36, 2008. ,
DOI : 10.1007/s10557-007-6076-5
Vulnerability to ventricular fibrillation related to ischemia: comparison of the acute effects of betablockers and calcium antagonists, Arch Int Pharmacodyn Ther, vol.327, pp.25-39, 1994. ,
Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes, Canadian Journal of Physiology and Pharmacology, vol.74, issue.12, pp.1308-1314, 1996. ,
DOI : 10.1139/y96-139
Delay by a calcium antagonist, amlodipine, of the onset of primary ventricular fibrillation in myocardial ischemia, Cardiovascular Drugs and Therapy, vol.46, issue.Suppl 1, pp.447-454, 1996. ,
DOI : 10.1007/BF00051109
Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ, Pharmacotherapy, vol.17, pp.737-745, 1997. ,
Extracellular potassium accumulation in acute myocardial ischemia*, Journal of Molecular and Cellular Cardiology, vol.16, issue.5, pp.389-394, 1984. ,
DOI : 10.1016/S0022-2828(84)80610-0
Internal pH, Na+, and Ca2+ regulation by trimetazidine during cardiac cell acidosis, Cardiovascular Drugs and Therapy, vol.50, issue.Suppl 26, pp.677-686, 1988. ,
DOI : 10.1007/BF02125756
Effects of acute hyperkalemia on cardiac excitability, American Heart Journal, vol.94, issue.6, pp.755-763, 1977. ,
DOI : 10.1016/S0002-8703(77)80217-2
Anti-ischaemic effect of ivabradine, Pharmacological Research, vol.53, issue.5, pp.435-439, 2006. ,
DOI : 10.1016/j.phrs.2006.03.018
Possibilities of reducing heart rate by I(f)-channel inhibitor, Med Klin (Munich), vol.101, pp.150-152, 2006. ,
Pharmacological Basics of ??-Current Inhibition, Heart Drug, vol.5, issue.1, pp.14-20, 2005. ,
DOI : 10.1159/000083381
The discovery of the selective If current inhibitor ivabradineA new therapeutic approach to ischemic heart disease, Pharmacological Research, vol.53, issue.5, pp.424-434, 2006. ,
DOI : 10.1016/j.phrs.2006.03.016
Arrhythmias during myocardial infarction: mechanisms, significance, and therapy, Cardiovasc Clin, vol.11, pp.81-102, 1980. ,
The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs, Journal of Anesthesia, vol.27, issue.Suppl, pp.341-343, 2006. ,
DOI : 10.1007/s00540-006-0429-2
Origin of ischemia-induced phase 1b ventricular arrhythmias in pig hearts, Journal of the American College of Cardiology, vol.39, issue.1, pp.166-176, 2002. ,
DOI : 10.1016/S0735-1097(01)01686-2
Departments of Nutrition ,
Heart rate as a treatable cardiovascular risk factor, British Medical Bulletin, vol.90, issue.1, pp.71-84, 2009. ,
DOI : 10.1093/bmb/ldp016
??-blockers: No longer an option for uncomplicated hypertension, Current Cardiology Reports, vol.115, issue.6, pp.441-446, 2007. ,
DOI : 10.1007/BF02938387
Are we misunderstanding beta-blockers, International Journal of Cardiology, vol.120, issue.1, pp.10-27, 2007. ,
DOI : 10.1016/j.ijcard.2007.01.069
Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment, American Journal of Ophthalmology, vol.134, issue.5, pp.749-760, 2002. ,
DOI : 10.1016/S0002-9394(02)01699-9
Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial, JAMA, vol.292, pp.2227-2236, 2004. ,
The Failing Heart ??? An Engine Out of Fuel, New England Journal of Medicine, vol.356, issue.11, pp.1140-1151, 2007. ,
DOI : 10.1056/NEJMra063052
Myocardial Substrate Metabolism in the Normal and Failing Heart, Physiological Reviews, vol.85, issue.3, pp.1093-1129, 2005. ,
DOI : 10.1152/physrev.00006.2004
??-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload, AJP: Endocrinology and Metabolism, vol.288, issue.6, pp.1120-1127, 2005. ,
DOI : 10.1152/ajpendo.00588.2004
Carvedilol versus Cardioselective ??-Blockers for the Treatment of Hypertension in Patients with Type 2 Diabetes Mellitus, Pharmacotherapy, vol.9, issue.2, pp.1491-1500, 2006. ,
DOI : 10.1007/s00228-004-0729-0
Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus, Am J Hypertens Am J Cardiol, vol.22105, issue.12, pp.151-15529, 2009. ,
The Funny Current, Drugs, vol.1015, issue.Supplement 2 ,
DOI : 10.2165/00003495-200767002-00003
Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49, British Journal of Pharmacology, vol.8, issue.Suppl. L, pp.37-42, 1994. ,
DOI : 10.1111/j.1476-5381.1994.tb13025.x
Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction, European Heart Journal, vol.29, issue.18, pp.2265-2275, 2008. ,
DOI : 10.1093/eurheartj/ehn337
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure, Circulation, vol.109, pp.1674-1679, 2004. ,
Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure, AJP: Heart and Circulatory Physiology, vol.296, issue.2, pp.435-441, 2009. ,
DOI : 10.1152/ajpheart.00591.2008
Effect of Graded Heart Rate Reduction with Ivabradine on Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs, Journal of Pharmacology and Experimental Therapeutics, vol.308, issue.1, pp.236-240, 2004. ,
DOI : 10.1124/jpet.103.059717
Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart, Cardiovascular Research, vol.84, issue.1, pp.72-82, 2009. ,
DOI : 10.1093/cvr/cvp158
Contributions of heart rate and contractility to myocardial oxygen balance during exercise, American Journal of Physiology - Heart and Circulatory Physiology, vol.284, issue.2, pp.676-682, 2003. ,
DOI : 10.1152/ajpheart.00564.2002
Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction, British Journal of Pharmacology, vol.33, issue.7, pp.970-971, 2008. ,
DOI : 10.1038/bjp.2008.347
Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents, British Journal of Pharmacology, vol.425, issue.Suppl L, pp.1589-1601, 2008. ,
DOI : 10.1038/sj.bjp.0707673
Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons, AJP: Heart and Circulatory Physiology, vol.286, issue.4, pp.1461-1470, 2004. ,
DOI : 10.1152/ajpheart.00942.2003
Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients, Transplantation, vol.88, pp.835-841, 2009. ,
Metabolic phenotyping of the diseased rat heart using 13C-substrates and ex vivo perfusion in the working mode, Mol Cell Biochem, vol.242, pp.89-99, 2003. ,
DOI : 10.1007/978-1-4757-4712-6_12
Effects of metoprolol and amiodarone combination on heart rate, myocardial contractility and coronary flow: Study in isolated perfused rat hearts, Exp Clin Cardiol, vol.9, pp.133-137, 2004. ,
AMPK and metabolic adaptation by the heart to pressure overload, AJP: Heart and Circulatory Physiology, vol.292, issue.1, pp.140-148, 2007. ,
DOI : 10.1152/ajpheart.00424.2006
Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study, J Cardiovasc Pharmacol, vol.52, pp.548-554, 2008. ,
Heart rate reduction improves myocardial ischemia in swine: role of interventricular blood flow redistribution, Am J Physiol, vol.261, pp.910-917, 1991. ,
Spatial heterogeneity of myocardial perfusion predicts local potassium channel expression and action potential duration, Cardiovascular Research, vol.77, issue.3 ,
DOI : 10.1093/cvr/cvm060
Heart Rate Slowing for Myocardial Dysfunction/Heart Failure, Adv Cardiol, vol.43, pp.97-105, 2006. ,
DOI : 10.1159/000095431
CHANGES IN THE IN VITRO PHARMACODYNAMIC PROPERTIES OF METOPROLOL IN ATRIA ISOLATED FROM SPONTANEOUSLY HYPERTENSIVE RATS, Clinical and Experimental Pharmacology and Physiology, vol.268, issue.3, pp.161-165, 2007. ,
DOI : 10.1126/science.8160017
Sodium???Hydrogen Exchange Inhibition and ??-Blockade Additively Decrease Infarct Size, The Annals of Thoracic Surgery, vol.83, issue.3, pp.1121-1127, 2007. ,
DOI : 10.1016/j.athoracsur.2006.10.039
Hemodynamic effects of orally administered carvedilol in healthy conscious dogs, American Journal of Veterinary Research, vol.66, issue.4, pp.637-641, 2005. ,
DOI : 10.2460/ajvr.2005.66.637
In Vitro and In Vivo Pharmacodynamic Properties of Metoprolol in Fructose-fed Hypertensive Rats, Journal of Cardiovascular Pharmacology, vol.51, issue.6, pp.532-541, 2008. ,
DOI : 10.1097/FJC.0b013e3181730306
Pharmacodynamics of carvedilol in conscious, healthy dogs Metoprolol prevents ischemia-reperfusion injury by reducing lipid peroxidation, J Vet Intern Med Jpn Circ J, vol.2063, issue.39, pp.297-304718, 1999. ,
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects, Proc Natl Acad Sci U S A, vol.93, pp.7375-7380, 1996. ,
Protective role of selenium supplementation against cardiac lesions induced by the combination of levomepromazine and risperidone in the rabbit, Human & Experimental Toxicology, vol.327, issue.8, pp.461-468, 2009. ,
DOI : 10.1177/0960327109106968
Cardiac Lesions Induced by Testosterone: Protective Effects of Dexrazoxane and Trimetazidine, Cardiovascular Toxicology, vol.7, issue.5A, pp.64-73, 2009. ,
DOI : 10.1007/s12012-009-9041-7
Heart lesions associated with anabolic steroid abuse: Comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits, Experimental and Toxicologic Pathology, vol.61, issue.4, pp.317-340, 2009. ,
DOI : 10.1016/j.etp.2008.09.007
Trimetazidine Protective Effect Against Ischemia-Induced Susceptibility to Ventricular Fibrillation in Pigs, Cardiovascular Drugs and Therapy, vol.79, issue.1, pp.29-36, 2008. ,
DOI : 10.1007/s10557-007-6076-5
Role of selenium in heart lesions produced by neuroleptics in the rabbit, Journal of Applied Toxicology, vol.87, issue.2, pp.212-218, 2008. ,
DOI : 10.1002/jat.1279